ClinicalThought

Share

Program Content

Activities

  • Melanoma Adjuvant Targeted Therapy
    My Thoughts on Adjuvant Targeted Therapy for BRAF V600E/K, High-Risk, Resected Melanoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 19, 2020

    Expires: October 18, 2021

  • Melanoma: First-line Tx
    How I Select Frontline Treatment in Metastatic Melanoma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 17, 2021

    Expires: February 16, 2022

  • Melanoma FAQ
    Experts Answer Frequently Asked Questions on Melanoma Management
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 03, 2021

    Expires: March 02, 2022

Faculty

cover img faculity

Allison Betof Warner, MD, PhD

Assistant Professor of Medicine (Oncology)
Director, Melanoma Medical Oncology Program
Director, Solid Tumor Cellular Therapy 
Leader, Melanoma & Cutaneous Oncology Clinical Research Group
Stanford University School of Medicine
Stanford, California

cover img faculity

Michael A. Davies, MD, PhD

Professor and Chair, Department of Melanoma Medical Oncology
Professor, Translational Molecular Pathology and Genomic Medicine
Anne and John Mendelsohn Chair in Cancer Research
University of Texas, MD Anderson Cancer Center
Houston, Texas

cover img faculity

Douglas T. Dieterich, MD

Professor of Medicine
Division of Liver Diseases
Director, Continuing Medical Education
Department of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Douglas Jacoby, MD

Associate Professor of Clinical Medicine
University of Pennsylvania Health System
Director
Penn Cardiology Preventive Care
Medical Director
Penn Presbyterian Heart and Vascular Pavilion
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania

cover img faculity

Ahmad Tarhini, MD, PhD

Assistant Professor of Medicine
Department of Medicine/Hematology-Oncology
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Novartis Pharmaceuticals Corporation